616455 Sigma-AldrichTGF-β1, Human, Recombinant, CHO Cell Line
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from a sterile filtered solution in 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 0.04-0.1 ng/ml |
Purity | ≥97% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1 EU/µg TGF-β1 |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
616455 | 0 |
Documentation
TGF-β1, Human, Recombinant, CHO Cell Line SDS
Title |
---|
TGF-β1, Human, Recombinant, CHO Cell Line Certificates of Analysis
Title | Lot Number |
---|---|
616455 |
References
Reference overview |
---|
Shibuya, H., et al. 1996. Science 272, 1179. Bottlinger, E.P., et al. 1995. Proc. Natl. Acad. Sci. USA 93, 5877. Lomo, J., et al. 1995. J. Immunol. 154, 1634. Marushige, K., and Marushige, Y. 1995. Anticancer Res. 14, 2419. Yamazaki, M., et al. 1994. Am. J. Pathol. 144, 221. |
Brochure
Title |
---|
TGF-b Signaling: Dual Role in Tumor Suppression and Oncogenesis |